Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans

Psychiatric Services

Volumn 59, Issue 10, 2008, Pages 1184-1190

  Harpaz Rotem, Ilan ^a   Rosenheck, Robert A ^a   Mohamed, Somaia ^a   Desai, Rani A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC SEDATIVE AGENT; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; DYSTHYMIA; FEMALE; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; POSTTRAUMATIC STRESS DISORDER; SCHIZOPHRENIA;

EID: 53549124706     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2008.59.10.1184     Document Type: Article

References (32)

1. Motor Vehicle Traffic Crash Fatality Counts and Estimates of People Injured, 2006. Washington DC, National Highway Traffic Safety Administration, National Center for Statistics and Analysis, 2007
2. Tjaden P, Thoennes N: Prevalence, Incidence and Consequences of Violence Against Women: Findings From the National Violence Against Women Survey. Washington, DC, Department of Justice, National Institute of Justice, 1998
3. Institute of Medicine: Treatment of PTSD: An Assessment of the Evidence. Washington, DC, National Academies Press, 2007
4. Mohamed S, Rosenheck RA: Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. Journal of Clinical Psychiatry 69:959-965, 2008
5. Foa EB, Keane TM, Friedman M: Effective Treatments for PTSD: Practice Guideline From the International Society of Traumatic Stress Studies. New York, Guilford, 2000
6. Harpaz-Rotem I, Rosenheck RA: Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness. Child Care Health and Development 32:225-237, 2006
7. Olfson M, Gameroff MJ, Marcus SC, et al: Outpatient treatment of child and adolescent depression in the United States. Archives of General Psychiatry 60:1236-1242, 2003
8. Olfson M, Marcus SC, Druss B, et al: National trends in the outpatient treatment of depression. JAMA 287:203-209, 2002
9. Brady KT, Killeen TK, Brewerton T, et al: Comorbidity of psychiatric disorders and posttraumatic stress disorder. Journal of Clinical Psychiatry 61:22-32, 2000
10. Van der Kolk BA, Dreyfuss D, Michaels M, et al: Fluoxetine in posttraumatic stress disorder. Journal of Clinical Psychiatry 55:517-522, 1994
11. Zohar J, Amital D, Miodownik C, et al: Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. Journal of Clinical Psychopharmacology 22:190-195, 2002
12. Hertzberg MA, Feldman ME, Beckham JC, et al: Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Annals of Clinical Psychiatry 12:101-105, 2000
13. Braun P, Greenberg D, Dasberg H, et al: Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry 51:236-238, 1990
14. Gelpin E, Bonne O, Peri T, et al: Treatment of recent trauma survivors with benzodiazepines: a prospective study. Journal of Clinical Psychiatry 57:390-394, 1996
15. Mellman TA, Bustamante V, David D, et al: Hypnotic medication in the aftermath of trauma. Journal of Clinical Psychiatry 63:1183-1184, 2002
16. Ballenger JC, Davidson JR, Lecrubier Y, et al: Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry 61:60-66, 2000
17. Butterfield MI, Becker ME, Connor KM, et al: Olanzapine in the treatment of posttraumatic stress disorder: a pilot study. International Clinical Psychopharmacology 16:197-203, 2001
18. Stein MB, Kline NA, Matloff JL: Adjunctive olanzapine for SSRI-resistant combatrelated PTSD: a double-blind, placebo-controlled study. American Journal of Psychiatry 159:1777-1779, 2002
19. Hamner MB, Faldowski RA, Ulmer HG, et al: Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. International Clinical Psychopharmacology 18:1-8, 2003
20. Monnelly EP, Ciraulo DA, Knapp C, et al: Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. Journal Clinical Psychopharmacology 23:193-196, 2003
21. Taylor FB, Lowe K, Thompson C, et al: Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biological Psychiatry 59:577-581, 2006
22. Dierks MR, Jordan JK, Sheehan AH: Prazosin treatment of nightmares related to posttraumatic stress disorder. Annals of Pharmacotherapy 41:1013-1017, 2007
23. Petrakis IL, Leslie D, Rosenheck R: The use of antidepressants in alcohol-dependent veterans. Journal of Clinical Psychiatry 64:865-870, 2003
24. Stanton MW: Employer-sponsored health insurance: trends in cost and access. Research in Action [Agency for Healthcare Research and Quality], no 17, Sept 2004
25. Mellman TA, Clark RE, Peacock WJ: Prescribing patterns for patients with posttraumatic stress disorder. Psychiatric Services 54:1618-1621, 2003
26. Kozaric-Kovacic D, Pivac N, Muck-Seler D, et al: Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. Journal of Clinical Psychiatry 66:922-927, 2005
27. Ahearn EP, Mussey M, Johnson C, et al: Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study. International Clinical Psychopharmacology 21:29-33, 2006
28. Davis LL, Frazier EC, Williford RB, et al: Long-term pharmacotherapy for post-traumatic stress disorder. CNS Drugs 20:465-476, 2006
29. Van Liempt S, Vermetten E, Geuze E, et al: Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review. International Clinical Psychopharmacology 21:193-202, 2006
30. Villarreal G, Calais LA, Canive JM, et al: Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Psychopharmacology Bulletin 40:6-18, 2007
31. Pae C-U, Lim H-K, Peindl K, et al: The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Clinical Psychopharmacology 23:1-8, 2008
32. Olfson M, Blanco C, Liu L, et al: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63:679-685, 2006